(800) 913-2022 | CONTACT US

EUROIMMUN US IFA

The BIOCHIP technology developed by EUROIMMUN allows unrivaled quality and variety in IFA. When multiple BIOCHIPs coated with different substrates are arranged in one reaction field, antibodies against various organs or infectious agents can be investigated simultaneously.

Discover advantages for EUROIMMUN BIOCHIP

BIOCHIP Technology

The BIOCHIP technology developed by EUROIMMUN allows unrivaled quality and variety in IFA.

BIOCHIP Technology

Images shown are for illustration purposes only and do not accurately represent available product configurations or true microscopy image quality.

EUROIMMUN US Product Portfolio

EUROIMMUN US is one of the leading manufacturers of medical laboratory diagnostics worldwide and stands for innovation.

EUROIMMUN US Autoimmune diagnostics

Autoimmune diagnostics

EUROIMMUN US Allergy diagnostics

Allergy diagnostics

EUROIMMUN US Antigen detection

Antigen detection

EUROIMMUN US Infection diagnostics

Infection diagnostics

EUROIMMUN US Molecular genetic diagnostics

Molecular genetic diagnostics

EUROIMMUN US Veterinary diagnostics

Veterinary diagnostics

For further product information, please visit our EUROIMMUN US products page

Automation solutions

EUROLab Workstation ELISA

The EUROLabWorkstation ELISA is a fully automated complete solution for processing ELISA kits in laboratories with high sample throughput.

Learn More about EUROLab Workstation ELISA

EUROLab Workstation ELISA

Latest from EUROIMMUN US

February 3, 2022

U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus

November 30, 2021

New SARS-CoV-2 variants of concern (VOC), variants of interest (VUI) or under monitoring (VUM)

October 5, 2021

EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization

June 24, 2021

SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma and Delta

June 18, 2020

COVID-19 RT-PCR Test Receives FDA Emergency Use Authorization

May 5, 2020

FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies

April 17, 2020

ABC News: Largest antibody study could answer crucial coronavirus questions

July 25, 2019

PerkinElmer and EverlyWell Announce Collaboration to Expand U.S. At-Home Health Test Market

April 3, 2019

PerkinElmer Receives FDA Clearance for EUROIMMUN Anti-Tissue Transglutaminase ELISA

November 20, 2018

Membranous Nephropathy: Antibody-based diagnosis, prognosis, and disease monitoring

June 20, 2018

PerkinElmer’s EUROIMMUN Receives 510(k) Clearance for Crithidia luciliae and Crithidia luciliae Sensitive Diagnostic Tests

February 27, 2018

Measles and Mumps Forgotten Diseases of Recurring Relevance

July 27, 2017

Autoimmune Encephalitis – Anti NMDAR and Beyond

April 12, 2017

EUROIMMUN Announces Option Agreement with Roche on Zika Virus Serology

May 28, 2016

EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

April 19, 2016

Zika Virus: Anatomy of a Global Health Crisis

February 17, 2016

First Commercial Serological Tests Available for Zika Virus Detection

2023 EUROIMMUN US

Privacy Policy | Sitemap